{"id":"https://openalex.org/W4291674600","doi":null,"title":"Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study.","display_name":"Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study.","publication_year":2022,"publication_date":"2022-04-01","ids":{"openalex":"https://openalex.org/W4291674600","pmid":"https://pubmed.ncbi.nlm.nih.gov/35958975","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9341320"},"language":"en","primary_location":{"id":"pmid:35958975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35958975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Innovations in clinical neuroscience","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9341320/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101976114","display_name":"Masaru Nakamura","orcid":"https://orcid.org/0000-0002-8894-9792","observed_orcids":["https://orcid.org/0000-0002-8894-9792"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masaru Nakamura","raw_affiliation_strings":["Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan","Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center in Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan","institution_ids":[]},{"raw_affiliation_string":"Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center in Yamaguchi, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066840131","display_name":"Takahiko Nagamine","orcid":"https://orcid.org/0000-0002-0690-6271","observed_orcids":["https://orcid.org/0000-0002-0690-6271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takahiko Nagamine","raw_affiliation_strings":["Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan","Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center in Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan","institution_ids":[]},{"raw_affiliation_string":"Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center in Yamaguchi, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5458,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.59443116,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"19","issue":"4-6","first_page":"70","last_page":"77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9319999814033508},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.7310000061988831},{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":0.9330000281333923},{"id":"https://openalex.org/keywords/metabolic-parameters","display_name":"metabolic parameters","score":0.6990000009536743},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9750000238418579},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7519999742507935},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.8429999947547913},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9639999866485596},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.5139999985694885},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.8980000019073486},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.8799999952316284},{"id":"https://openalex.org/keywords/antipsychotic-dose","display_name":"antipsychotic dosing","score":0.6340000033378601},{"id":"https://openalex.org/keywords/psychiatric-inpatients","display_name":"psychiatric inpatients","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.9890447854995728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7579072713851929},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.6417767405509949},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.5548228621482849},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4936724603176117},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.48545724153518677},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.4831949770450592},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.4595555067062378},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4538132846355438},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.4485276937484741},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4452826678752899},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.329853892326355},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.28793221712112427},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.25001153349876404},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.1992967426776886},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:35958975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35958975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Innovations in clinical neuroscience","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9341320","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9341320/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Innov Clin Neurosci","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:9341320","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9341320/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Innov Clin Neurosci","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1966949437","https://openalex.org/W1974105639","https://openalex.org/W1981740077","https://openalex.org/W1991916074","https://openalex.org/W1997910708","https://openalex.org/W2002278536","https://openalex.org/W2039404912","https://openalex.org/W2043973417","https://openalex.org/W2044736948","https://openalex.org/W2047169243","https://openalex.org/W2076534816","https://openalex.org/W2137044087","https://openalex.org/W2622469380","https://openalex.org/W2765914721","https://openalex.org/W2854549530","https://openalex.org/W2920711593","https://openalex.org/W2927762704","https://openalex.org/W2957311488","https://openalex.org/W2958423778","https://openalex.org/W2980826392","https://openalex.org/W2982167270","https://openalex.org/W2989476205","https://openalex.org/W3038657658","https://openalex.org/W3080584333","https://openalex.org/W3101351365","https://openalex.org/W3156330980","https://openalex.org/W3177208030","https://openalex.org/W3192812708","https://openalex.org/W3194850247"],"related_works":["https://openalex.org/W2014065211","https://openalex.org/W3023858149","https://openalex.org/W3093788383","https://openalex.org/W2490619074","https://openalex.org/W2535024064","https://openalex.org/W7138200896","https://openalex.org/W4404468660","https://openalex.org/W1990582321","https://openalex.org/W2794827704","https://openalex.org/W3086858479"],"abstract_inverted_index":{"Objective:":[0],"Lurasidone":[1,208],"is":[2,32],"a":[3],"second-generation":[4],"antipsychotic":[5,10],"(SGA)":[6],"that":[7,127],"contributes":[8],"an":[9],"and":[11,20,52,66,72,114,138,147,165,180,193,200,221,237,248],"antidepressant":[12],"effect,":[13],"with":[14,77,197,230],"low":[15],"incidences":[16],"of":[17,25,45,61,107,124,162,167,245],"metabolic-related":[18],"diseases":[19],"hyperprolactinemia":[21],"for":[22,213],"the":[23,43,59,145,211],"treatment":[24,48],"psychological":[26],"disorders.":[27,79],"However,":[28],"evidence":[29],"on":[30,49],"lurasidone":[31,47,64,152,177,183],"limited":[33],"in":[34,56,69,104],"psychiatric":[35,62,78],"clinical":[36],"settings.":[37],"This":[38],"study":[39],"aimed":[40],"to":[41,58,174,186,253],"investigate":[42],"effect":[44],"short-term":[46],"metabolic":[50,108,125,140],"effects":[51],"prolactin":[53],"(PRL)":[54],"levels,":[55,205,220],"relation":[57],"differences":[60],"disorders,":[63],"dosages,":[65],"introducing":[67],"methods,":[68],"35":[70],"female":[71],"12":[73],"male":[74],"Japanese":[75],"inpatients":[76],"Methods:":[80],"Subjects":[81],"were":[82,120,128,133],"placed":[83],"into":[84],"six":[85],"subgroups":[86],"divided":[87],"by":[88],"three":[89],"categories":[90],"(schizophrenia/schizoaffective":[91],"disorder":[92],"or":[93,97,100],"bipolar":[94],"disorder,":[95],"20mg/day":[96],"40mg/day,":[98],"adding":[99],"switching).":[101],"Sequential":[102],"changes":[103],"10":[105],"items":[106],"parameters,":[109],"including":[110],"estimated":[111],"insulin":[112,247],"resistance":[113],"PRL":[115,171,224],"levels":[116,161,166,172],"at":[117],"one":[118],"month,":[119],"evaluated.":[121],"The":[122],"variations":[123],"parameters":[126],"significantly":[129,153],"changed":[130],"from":[131,187],"baseline":[132],"analyzed":[134],"against":[135],"sample":[136],"characteristics":[137],"other":[139,188],"parameter":[141],"variations.":[142],"Results:":[143],"In":[144],"40mg/day":[146],"switching":[148,227],"introduction":[149,191,228],"method":[150,192,229],"groups,":[151],"reduced":[154],"body":[155,157],"weight,":[156],"mass":[158],"index":[159],"(BMI),":[160],"alanine":[163],"amiotransaminase,":[164],"fasting":[168,202],"blood":[169,203,218],"glucose.":[170],"seemed":[173],"increase":[175],"when":[176,182],"was":[178,184],"added":[179],"decrease":[181],"switched":[185],"antipsychotics.":[189],"Switching":[190],"higher":[194,231],"dosage":[195],"correlated":[196],"weight":[198,214],"loss":[199],"lowering":[201],"glucose":[204,219,238],"respectively.":[206],"Conclusion:":[207],"administration":[209],"offered":[210],"potential":[212],"loss,":[215],"lowered":[216],"serum":[217,223,246],"converging":[222],"concentrations.":[225],"Moreover,":[226],"dosages":[232],"might":[233],"alleviate":[234],"basal":[235],"metabolism":[236],"homeostasis.":[239],"Further":[240],"prospective":[241],"studies":[242],"combining":[243],"measurements":[244],"psychometric":[249],"evaluation":[250],"will":[251],"help":[252],"confirm":[254],"our":[255],"conclusions.":[256]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-08-15T00:00:00"}